TABLE II.
Feno level | ||
---|---|---|
<25 ppb (<20 in children aged 5–12 y) | 25–50 ppb (20–35 in children aged 5–12 y) | >50 ppb (>35 in children aged 5–12 y) |
• Recent or current corticosteroid use | • Evaluate in clinical context | • Eosinophilic airways inflammation likely |
• Alternative diagnoses | • Consider other diagnoses | • Phenotype more likely to respond to ICS |
• Phenotype less likely to benefit from ICS | • Consider other factors influencing result | • Allergic asthma |
• Noneosinophilic asthma | • Eosinophilic asthma less likely | • Eosinophilic bronchitis |
• COPD | ||
• Bronchiectasis | ||
• CF | ||
• Vocal cord dysfunction | ||
• Rhinosinusitis | ||
• Smoking | ||
• Obesity |
CF, Cystic fibrosis; COPD, chronic obstructive pulmonary disease.
Reprinted with permission of the American Thoracic Society, ©2019 American Thoracic Society. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications. Am J Respir Crit Care Med 2011;184:602–15. The American Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society.